The Scientist

» pharmaceuticals and evolution

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Contributors


By | January 1, 2015

Meet some of the people featured in the January 2015 issue of The Scientist.


image: Performance Art

Performance Art

By | January 1, 2015

Regulation of genome expression orchestrates the behavior of insect castes and the human response to social stress.


image: Why, Oh Y?

Why, Oh Y?

By | January 1, 2015

A toothpick and a bit of chance shaped David Page’s career, which he has dedicated to understanding the mammalian Y chromosome and fetal germ cell development.


image: The Genetics of Society

The Genetics of Society

By | January 1, 2015

Researchers aim to unravel the molecular mechanisms by which a single genotype gives rise to diverse castes in eusocial organisms.


image: Unraveling H7N9’s History

Unraveling H7N9’s History

By | December 30, 2014

An analysis of stored samples shows that H7N9 precursor H9N2, a virus widespread in chickens, has shown increased fitness in recent years.


image: Behavior Brief

Behavior Brief

By | December 18, 2014

A round-up of recent discoveries in behavior research


image: Iron-Ferrying Protein Impedes Pathogens

Iron-Ferrying Protein Impedes Pathogens

By | December 15, 2014

Meningitis-causing bacteria exerted strong evolutionary pressure on an iron-binding protein in primates, a study shows.


image: Bird Genomes Abound

Bird Genomes Abound

By | December 11, 2014

Scientists complete the largest-ever comparative genomic study of birds.

1 Comment

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.


Popular Now

  1. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  2. Inside a Lab Mouse’s High-Fat Diet
  3. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  4. How Gastric Bypass Can Kill Sugar Cravings
Life Technologies